Corvus Capital Ltd. - Jun 3, 2025 SCHEDULE 13D/A Report for Conduit Pharmaceuticals Inc. Common Stock, par value $0.0001 per share

Filing Manager: Corvus Capital Ltd.
Reporting Manager: Andrew Regan
Security: Conduit Pharmaceuticals Inc. Common Stock, par value $0.0001 per share
Shares outstanding: 2.92M shares
Disclosed Ownership: 175K shares
Ownership: 6%
Form type: SCHEDULE 13D/A
Date filed: 7/31/2025, 07:46 PM
Date of event: Jun 3, 2025
Next filing: Sep 22, 2025
SEC: View on sec.gov

Reporting Managers (4)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Corvus Capital Ltd.	6%	175K	0	175K	/s/ Andrew Regan	Andrew Regan/Chief Executive Officer	0001990829
Andrew Regan	6%	175K	44	175K	/s/ Andrew Regan	Andrew Regan	0001991325
Algo Holdings, Inc.	0%	118	0	118	/s/ Alexander Lambert	Alexander Lambert/Director	0001991236
Manoira Corporation	5.3%	155K	0	155K	/s/ Andrew Regan	Andrew Regan/Director	0002077215